These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28036370)

  • 1. Fcγ-receptor IIa-mediated Src Signaling Pathway Is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection.
    Furuyama W; Marzi A; Carmody AB; Maruyama J; Kuroda M; Miyamoto H; Nanbo A; Manzoor R; Yoshida R; Igarashi M; Feldmann H; Takada A
    PLoS Pathog; 2016 Dec; 12(12):e1006139. PubMed ID: 28036370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection.
    Furuyama W; Nanbo A; Maruyama J; Marzi A; Takada A
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008602. PubMed ID: 32886656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
    Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T
    Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors.
    Kuzmina NA; Younan P; Gilchuk P; Santos RI; Flyak AI; Ilinykh PA; Huang K; Lubaki NM; Ramanathan P; Crowe JE; Bukreyev A
    Cell Rep; 2018 Aug; 24(7):1802-1815.e5. PubMed ID: 30110637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection.
    Chotiwan N; Roehrig JT; Schlesinger JJ; Blair CD; Huang CY
    Virology; 2014 May; 456-457():238-46. PubMed ID: 24889243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
    Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M
    PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications.
    Takada A; Kawaoka Y
    Rev Med Virol; 2003; 13(6):387-98. PubMed ID: 14625886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection.
    Boonnak K; Slike BM; Donofrio GC; Marovich MA
    J Immunol; 2013 Jun; 190(11):5659-65. PubMed ID: 23616574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.
    Boonnak K; Slike BM; Burgess TH; Mason RM; Wu SJ; Sun P; Porter K; Rudiman IF; Yuwono D; Puthavathana P; Marovich MA
    J Virol; 2008 Apr; 82(8):3939-51. PubMed ID: 18272578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection.
    Moi ML; Lim CK; Takasaki T; Kurane I
    J Gen Virol; 2010 Jan; 91(Pt 1):103-11. PubMed ID: 19776239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2-mediated enhancement of Ebola virus entry.
    Kuroda M; Halfmann P; Kawaoka Y
    PLoS Pathog; 2020 Oct; 16(10):e1008900. PubMed ID: 33052961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages.
    Maemura T; Kuroda M; Armbrust T; Yamayoshi S; Halfmann PJ; Kawaoka Y
    mBio; 2021 Oct; 12(5):e0198721. PubMed ID: 34579572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors.
    Mady BJ; Erbe DV; Kurane I; Fanger MW; Ennis FA
    J Immunol; 1991 Nov; 147(9):3139-44. PubMed ID: 1680925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.
    Favier AL; Gout E; Reynard O; Ferraris O; Kleman JP; Volchkov V; Peyrefitte C; Thielens NM
    J Virol; 2016 Jun; 90(11):5256-5269. PubMed ID: 26984723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola Virus Uptake into Polarized Cells from the Apical Surface.
    Hu M; Wang F; Li W; Zhang X; Zhang Z; Zhang XE; Cui Z
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31810353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitopes required for antibody-dependent enhancement of Ebola virus infection.
    Takada A; Ebihara H; Feldmann H; Geisbert TW; Kawaoka Y
    J Infect Dis; 2007 Nov; 196 Suppl 2():S347-56. PubMed ID: 17940970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32).
    Rodrigo WW; Jin X; Blackley SD; Rose RC; Schlesinger JJ
    J Virol; 2006 Oct; 80(20):10128-38. PubMed ID: 17005690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entry of Ebola Virus is an Asynchronous Process.
    Reynard O; Volchkov VE
    J Infect Dis; 2015 Oct; 212 Suppl 2():S199-203. PubMed ID: 25941332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola virus requires a host scramblase for externalization of phosphatidylserine on the surface of viral particles.
    Nanbo A; Maruyama J; Imai M; Ujie M; Fujioka Y; Nishide S; Takada A; Ohba Y; Kawaoka Y
    PLoS Pathog; 2018 Jan; 14(1):e1006848. PubMed ID: 29338048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.